logo
Impact Radar
  • Overview
  • Impact Performance
  • Compare this company
  • All sources
    • Sign UpLog In
    logo

    Recursion Pharmaceuticals | Sustainability & Chart

    US75629V1044

    Basic information on Recursion Pharmaceuticals

    Location: United Kingdom

    Industry: Health Services

    Website

    knob-globe
    68%

    Impact Score

    Description Recursion Pharmaceuticals

    Recursion Pharmaceuticals Inc. is a biotechnology company that uses AI and automation to accelerate drug discovery and development, focusing on rare diseases and other therapeutic areas.

    Recursion Pharmaceuticals Sustainability Performance

    Renewable Energy
    Greenhouse Gas Emissions
    Supply Chain
    Waste Recycling
    Sustainable [100]
    Almost sustainable [67-99]
    Moderate [34-66]
    Not sustainable [0-33]
    No data
    We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

    Compare Recursion Pharmaceuticals with ...

    Recursion Pharmaceuticals

    ?

    Impact Score

    knob-globe
    68%
    knob-globe
    0%
    Climate
    Society
    Gender

    Sources of sustainability performance

    MetricValueUnitYearPDF NamePDF Page
    CEO-to-Employee Pay Ratio
    CEO-to-median-salary-ratio28ratio2024RXRX Proxy Statement 2025.pdf60
    CEO nameChris Gibson2024RXRX Proxy Statement 2025.pdf6
    Employee turnover rate
    Employee turnover17%2024Recursion ESG Report 2025 - FINAL.pdf38
    Gender Pay Gap
    Unadjusted gender pay gap1%2024Recursion ESG Report 2025 - FINAL.pdf34
    Glass Ceiling
    Women in workforce44%2024Recursion ESG Report 2025 - FINAL.pdf55
    Women in management37%2024Recursion ESG Report 2025 - FINAL.pdf33
    Greenhouse Gas Emissions
    Scope 1 emissions586mtCO2e2024Recursion ESG Report 2025 - FINAL.pdf56
    Number of employees800EMPLOYEES2024RXRX Proxy Statement 2025.pdf11
    Scope 2 emissions, location based3 342mtCO2e2024Recursion ESG Report 2025 - FINAL.pdf56
    Harassment and Discrimination at the Workplace
    Incident notification mechanismYes2024RP - Code of Business Conduct and Ethics.pdf8
    Retaliation safeguardsYes2024RP - Code of Business Conduct and Ethics.pdf8
    Confidentiality mechanismsYes2024RP - Code of Business Conduct and Ethics.pdf8
    Anti-discrimination policyYes2024RP - Code of Business Conduct and Ethics.pdf5
    Supply Chain
    Scope 3 emissions28 135mtCO2e2024Recursion ESG Report 2025 - FINAL.pdf56
    Number of employees800EMPLOYEES2024RXRX Proxy Statement 2025.pdf11
    Scope 2 emissions, location based3 342mtCO2e2024Recursion ESG Report 2025 - FINAL.pdf56
    Scope 1 emissions586mtCO2e2024Recursion ESG Report 2025 - FINAL.pdf56
    Recycling and Recovery of Waste
    Waste recycled5,44tons2024Recursion ESG Report 2025 - FINAL.pdf56
    Total waste generation12,24tons2024Recursion ESG Report 2025 - FINAL.pdf56
    Women on the Board
    Supervisory board size10DIRECTORS2024RXRX Proxy Statement 2025.pdf31
    Women on executive board2Officers2024RXRX Proxy Statement 2025.pdf39
    Executive board size6Officers2024RXRX Proxy Statement 2025.pdf39
    Women on supervisory board4DIRECTORS2024RXRX Proxy Statement 2025.pdf33
    Women in Management
    Women in management37%2024Recursion ESG Report 2025 - FINAL.pdf33
    Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

    Find more sustainable companies

    logo
    HomeFind Companies & ETFsLearn to investAcademyGlossaryOur Method
    ImprintPrivacy PolicyGTCFAQContact Us
    © 2025 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The source of ETF data is the websites and data sheets of the respective ETF providers.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!Logos provided by Logo.dev